|
|
|
Volumn 27, Issue 2, 2000, Pages 194-203
|
|
Interleukin-2 in the treatment of renal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOKINE;
RECOMBINANT INTERLEUKIN 2;
ANTINEOPLASTIC ACTIVITY;
CANCER IMMUNOTHERAPY;
CYTOTOXIC T LYMPHOCYTE;
DOSE RESPONSE;
DRUG INDUCED DISEASE;
HUMAN;
HYPOTENSION;
KIDNEY CARCINOMA;
LYMPHOKINE ACTIVATED KILLER CELL;
NATURAL KILLER CELL;
NEPHRECTOMY;
NEPHROTOXICITY;
NEUROTOXICITY;
PRIORITY JOURNAL;
REVIEW;
T LYMPHOCYTE SUBPOPULATION;
TUMOR ASSOCIATED LEUKOCYTE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS, PHASE I;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
KILLER CELLS, LYMPHOKINE-ACTIVATED;
NEPHRECTOMY;
SIGNAL TRANSDUCTION;
SURVIVAL RATE;
THYROIDITIS, AUTOIMMUNE;
|
|
EID: 0034074164
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (105)
|
|
References (82)
|
